Marketplace
CBC News: Marketplace
Bookmark this page | E-mail to a friend
MENU

MARKETPLACE: MAIN PAGE
MARKETPLACE MURMURS: MAIN PAGE MURMUR ARCHIVES
RECENT MURMURS:
Marketplace Murmurs is taking a break – in the meantime, if you have stories to share with the show, please contact us.
TOPICS:
Activism
Advertising
Cars/Auto Industry
The Environment
Food/Drink
Health/Safety
Home
Kids
Logos/Branding
Miscellaneous
Money/Finances
Privacy
Scams
Services
Technology
Travel
READINGS
Boing Boing
we make money not art
Advertising Age
The Trademark Blog
Treehugger
Darren Barefoot
Environmental Health News
Schneier on Security
Popgadget
Consumer World
Micropersuasion
A Consumer Reports
Adrants
Stay Free! Daily
adfreak
Consumer News (Industry Canada)
AdJab
Consumer Scribbler (Consumers Union)
The Consumerist
SCHEDULE

Watch Marketplace Fridays at 8:30PM

HOSTS & REPORTERS

NEWSLETTER

The Marketplace Newsletter keeps you on top of stories we're working on. You'll get the latest warnings and recalls delivered to your e-mail box every week. It's the best way to stay in the Marketplace loop.

Subscribe to our newsletter

Newsletter archive

HELP MARKETPLACE
Have an idea for a story you'd like to see on Marketplace? Get in touch with us!
MARKETPLACE MURMURS »
Marketplace Murmurs is a daily blog of consumer-related news, thoughts and missives that cross the minds and desks of the CBC News: Marketplace staff...

One less drug useful against flu, Ottawa says
January 16, 2006

Worth repeating from CBC Health and Science News:

In the depths of the flu season, federal health officials say a drug used to combat outbreaks in old-age homes and other institutions has lost its power against common flu germs.

The Public Health Agency of Canada is recommending that doctors stop prescribing amantadine to treat or prevent influenza. It suggests using Tamiflu or Relenza instead.

The health agency's weekend announcement is unrelated to the much-discussed threat of a bird flu pandemic. Scientists worry that a deadly strain of avian flu will mutate and spread more easily.

The public health agency's announcement deals with a flu virus already common among humans but seldom fatal to those in good health.

The agency's lab in Winnipeg tested 47 samples of H3N2 virus collected in British Columbia, Alberta, Saskatchewan and Ontario since September and found that 43 – or 91 per cent – were resistant to amantadine.

The announcement followed a similar warning on Friday from the U.S. Centers for Disease Control. Amantadine is also used to treat symptoms of Parkinson's disease and should continue to be used for that purpose, the CDC said.

The Canadian agency said people who had this year's flu shot are protected against the drug-resistant germs.

"The results are an important reminder that antiviral medications – which don't provide immunity – should not replace annual influenza immunization," it said.

via: CBC Health & Science News

related CBC Indepth: Faint Warning: How Canada tracks dangerous drugs

related murmurs: Chest doctors discourage use of most cough syrups, Few cold remedies backed with evidence, Ginseng-loaded ‘Cold-fX’ cuts frequency of common cold: study, Researchers explain why bundling up may prevent colds, Drugs killing thousands of seniors yearly

related Marketplace story: Out in the Cold

murmur categories:

tags:

posted by Tessa | 11:42 AM (ET) | Permalink




^TOP